George L. Sing - 06 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Issuer symbol
REGN
Transactions as of
06 Aug 2021
Net transactions value
-$4,255,877
Form type
4
Filing time
10 Aug 2021, 17:00:34 UTC
Next filing
13 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,834,290 -3,000 -5.5% $611.43 51,663 06 Aug 2021 Direct
transaction REGN Common Stock Sale $611,230 -1,000 -1.9% $611.23 50,663 06 Aug 2021 Direct
transaction REGN Common Stock Sale $369,000 -600 -1.2% $615.00 50,063 10 Aug 2021 Direct
transaction REGN Common Stock Sale $614,000 -1,000 -2% $614.00 49,063 10 Aug 2021 Direct
transaction REGN Common Stock Sale $613,010 -1,000 -2% $613.01 48,063 10 Aug 2021 Direct F1
transaction REGN Common Stock Sale $214,347 -350 -9.5% $612.42 3,350 06 Aug 2021 by Trust for Son
holding REGN Common Stock 1,150 06 Aug 2021 by Spouse
holding REGN Common Stock 400 06 Aug 2021 by Spouse/Cust Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 10, 2021 at prices ranging from $613.00 to $613.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.